IL17RB and neoplasm: CRL4-DCAF1 ubiquitinates Large tumor suppressor kinase 1/2 (LATS1/2), and prevents Yes-associated protein (YAP) phosphorylation, thus inhibiting the Hippo tumour suppressor pathway and supporting tumour growth [13].